SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-009541
Filing Date
2018-02-16
Accepted
2018-02-16 16:05:23
Documents
8
Period of Report
2018-02-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv486363_8k.htm 8-K 66786
2 EXHIBIT 3.1 tv486363_ex3-1.htm EX-3.1 93349
3 EXHIBIT 10.1 tv486363_ex10-1.htm EX-10.1 56949
4 EXHIBIT 10.2 tv486363_ex10-2.htm EX-10.2 46346
5 EXHIBIT 10.3 tv486363_ex10-3.htm EX-10.3 72581
6 EXHIBIT 10.4 tv486363_ex10-4.htm EX-10.4 97097
7 EXHIBIT 99.1 tv486363_ex99-1.htm EX-99.1 11225
8 EXHIBIT 99.2 tv486363_ex99-2.htm EX-99.2 11053
  Complete submission text file 0001144204-18-009541.txt   457208
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34951 | Film No.: 18621203
SIC: 2836 Biological Products, (No Diagnostic Substances)